Biogen Inc. closed 46.82% short of its 52-week high of $238.00, which the company achieved on July 12th.

Biogen's BIIB -3.42% Get Free Report short percent of float has risen 13.95% since its last report. The company recently reported that it has 3.80 million shares sold short, which is 3.35% of all ...

Biogen Inc. (NASDAQ:BIIB) is one of the 15 best stocks to invest in for an 18 year old. On June 10, Biogen Inc.

SUPN inks deal to acquire Sage Therapeutics for up to $795 million, securing rights to depression drug Zurzuvae.

Big Pharma executives have not been shy about their desire for deals, but companies have been battling macro headwinds ...

With Viatris taking home the biggest prize at this year’s Cannes Pharma Lions award and Biogen winning Gold, pharma is making ...

Maxion Therapeutics (“Maxion”), a biotechnology company developing antibody-based KnotBody® drugs for ion channel and G ...

Cambridge, UK-based Maxion Therapeutics today announced the appointment of Dr Stefan Härtle as chief development officer, ...

From Grand Prix to Bronze, see which US agencies and production companies are cleaning up at Cannes this year.

Virtualware (EPA:MLVIR), a pioneer in 3D-driven enterprise software, will uplist to Euronext Growth Paris on June 19 under the ticker ALVIR, following approval by the exchange's ...